Disease and Security: Natural plagues and biological weapons in East Asia

Disease and Security: Natural plagues and biological weapons in East Asia

Volumn , Issue , 2007, Pages 1-229

  Enemark, Christian ^a,b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84906604117     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.4324/9780203089019     Document Type: Book

References (326)

1. R. Paris, ‘Human security: paradigm shift or hot air?’, International Security 26, 2, 2001, 87–102, p. 95.
2. NIC, The Global Infectious Disease Threat and its Implications for the United States (National Intelligence Council Online, January 2000). Online, available at: www.dni.gov/nic/special_globalinfectious.html (accessed 31 August 2006).
3. R.J. Jackson, A.J. Ramsay, C.D. Christensen, S. Beaton, D.F. Hall and I.A. Ramshaw, ‘Expression of mouse Interleukin-4 by a recombinant ectromelia virus suppresses cytolytic lymphocyte responses and overcomes genetic resistance to mousepox’, Journal of Virology 75, 3, 2001, 1205–1210.
4. J. Youde, ‘Enter the fourth horseman: health security and international relations theory’, Whitehead Journal of Diplomacy and International Relations 6, 1, 2005, 193–208, p. 194.
5. S. Elbe, Strategic Implications of HIV/AIDS, Adelphi Paper 357, New York: Oxford University Press, 2003
6. G. Prins, ‘AIDS and global security’, International Affairs 80, 5, 2004, 931–952
7. P.W. Singer, ‘AIDS and international security’, Survival 44, 1, 2002, 145–158.
8. S. Szreter, ‘Health and security in historical perspective’, in Global Health Challenges for Human Security, L. Chen, J. Leaning and V. Narasimhan (eds), Cambridge, MA: Global Equity Initiative, Asia Center, Harvard University, 2003, p. 31.
9. Livy, The War With Hannibal, A.D. Selincourt (trans.), London: Penguin, 1965, pp. 331–332.
10. E. Croddy, Chemical and Biological Warfare: a Comprehensive Survey for the Concerned Citizen, New York: Copernicus, 2002, pp. 249–250.
11. H. Zinsser, Rats, Lice, and History, London: Routledge, 1937, p. 165.
12. S. Selin, ‘The security implications of SARS’, CANCAPS Bulletin 37, 2003, 9–13, p. 10.
13. R.J. Evans, ‘Epidemics and revolutions: cholera in nineteenth–century Europe’, in Epidemics and Ideas: Essays on the Historical Perception of Pestilence, T. Ranger and P. Slack (eds), New York: Cambridge University Press, 1992, p. 159.
14. T. Price-Smith, The Health of Nations: Infectious Disease, Environmental Change, and Their Effects on National Security and Development, Cambridge, MA: MIT Press, 2002, p. 128.
15. G.H. Brundtland, New Global Challenges: Health and Security from HIV to SARS (WHO Online, 18 July 2003). Online, available at: www.who.int/dg/brundt- land/speeches/2003/genevasecuritypolicy/en/print.html (accessed 6 January 2005).
16. M. Wheelis, L. Rozsa and M. Dando (eds), Deadly Cultures: Biological Weapons since 1945, Cambridge, MA: Harvard University Press, 2006.
17. MIIS, Chemical and Biological Weapons: Possession and Programs Past and Present (Monterey Institute of International Studies Online, 9 April 2002). Online, available at: cns.miis.edu/research/cbw/possess.htm (accessed 1 September 2006).
18. C. McInnes, ‘Health and security studies’, in Health, Foreign Policy and Security A. Ingram (ed.), London: Nuffield Trust, 2004, pp. 44–46.
19. P. Chalk, ‘Disease and the complex process of securitization in the Asia– Pacific’, in Non–Traditional Security in Asia: Dilemmas in Securitisation, M. Caballero-Anthony, R. Emmers and A. Acharya (eds), Aldershot: Ashgate, 2006
20. S. Elbe, ‘Should HIV/AIDS be securitized? The ethical dilemmas of linking HIV/AIDS and security’, International Studies Quarterly 50, 1, 2006, 119–144.
21. Buzan, O. Waever and J.d. Wilde, Security: a New Framework for Analysis, London: Lynne Rienner, 1998, pp. 23–24.
22. O. Waever, ‘Securitization and desecuritization’, in On Security, R.D. Lipschutz (ed.), New York: Columbia University Press, 1995, p. 57.
23. Buzan, People, States and Fear: an Agenda for International Security Studies in the Post-Cold War Era, 2nd edn, London: Harvester Wheatsheaf, 1991, p. 115
24. P. Slovic, B. Fischhoff and S. Lichtenstein, ‘Facts and fears: understanding perceived risk’, in Societal Risk Assessment: How Safe is Safe Enough? R.C. Schwing and W.A. Albers (eds), New York: Plenum, 1980, p. 209.
25. WHO, World Health Report 2002: Reducing Risks, Promoting Healthy Life, World Health Organization, 2002, p. 32.
26. H. Schell, ‘Outburst! A chilling true story about emerging-virus narratives and pandemic social change’, Configurations 5, 1, 1997, p. 96.
27. J. Stern, ‘Dreaded risks and the control of biological weapons’, International Security 27, 3, 2002, p. 102.
28. R. Chandavarkar, ‘Plague panic and epidemic politics in India, 1896–1914’, in Epidemics and Ideas: Essays on the Historical Perception of Pestilence, T. Ranger and P. Slack (eds), New York: Cambridge University Press, 1992, pp. 203–204.
29. R. Ullman, ‘Redefining security’, International Security 8, 1, 1983, p. 133.
30. A.J. Bellamy and M. McDonald, ‘“The utility of human security”: which humans? What Security? A reply to Thomas and Tow’, Security Dialogue 33, 3, 2002, p. 374.
31. UN, A More Secure World: Our Shared Responsibility. Report of the High–Level Panel on Threats, Challenges and Change, United Nations, 2004, p. 19.
32. McInnes ‘Health and security studies’, in Health, Foreign Policy and Security, A. Ingram (ed.). London: Nuffield Trust, 2004, p. 54.
33. Y.S. Wong and G. Chan, The SAF SARS Diaries, Singapore Armed Forces, 2004, p. 33.
34. P. Fidler, Germs, Norms and Power: Global Health’s Political Revolution (Law, Social Justice & Global Development Online, 4 June 2004). Online, available at: www2.warwick.ac.uk/fac/soc/law/elj/lgd/2004_1/fidler/ (accessed 19 September 2006).
35. W. Orent, ‘An “illegal” outbreak of plague’, Los Angeles Times 8 August 2004,
36. E. Emanuel and A. Wertheimer, ‘Who should get influenza vaccine when not all can?’, Science 312, 5775, 2006, 854–855.
37. McInnes and K. Lee, ‘Health, security and foreign policy’, Review of International Studies 32, 1, 2006, 5–23, p. 11.
38. Yach, S.R. Leeder, J. Bell and B. Kistnasamy, ‘Global chronic diseases’, Science 307, 5708, 2005, 317.
39. Wang, L. Kong, F. Wu, Y. Bai and R. Burton, ‘Preventing chronic diseases in China’, The Lancet 366, 9499, 2005, 1821–1824.
40. Feldbaum and K. Lee, ‘Public health and security’, in Health, Foreign Policy and Security, A. Ingram (ed.). London: Nuffield Trust, 2004, p. 22.
41. R. Thakur, ‘From national to human security’, in Asia-Pacific Security: The Economics-Politics Nexus, S. Harris and A. Mack (eds). Sydney: Allen & Unwin, 1997, pp. 53–54.
42. Human Security Centre, Human Security Report 2005: War and Peace in the 21st Century, University of British Columbia, 2005, p. viii.
43. UNDP, Human Development Report, United Nations Development Program, 1994.
44. Acharya, ‘Human security: what kind for the Asia-Pacific?’, in The Human Face of Security: Asia-Pacific Perspectives, D. Dickens (ed.), Canberra Paper on Strategy and Defence No. 144, Canberra: Australian National University, 2002, p. 5.
45. Y. Huang, Mortal Peril: Public Health in China and its Security Implications, Washington, DC: Chemical and Biological Arms Control Institute, 2003, p. 69.
46. J.S.M. Peiris, S.T. Lai, L.L.M. Poon, Y. Guan, L.Y.C. Yam, W. Lim, J. Nicholls, W.K.S. Yee, W.W. Yan and M.T. Cheung, ‘Coronavirus as a possible cause of severe acute respiratory syndrome’, The Lancet 361, 9366, 2003, 1319–1325.
47. S.V. Lawrence, ‘The plague reaches much deeper’, Far Eastern Economic Review 1 May 2003, 26–29, p. 26.
48. M. Curley and N. Thomas, ‘Human security and public health in Southeast Asia: the SARS outbreak’, Australian Journal of International Affairs 58, 1, 2004, 17–32, at p. 25.
49. M.-S. Ho and I.-J. Su, ‘Preparing to prevent severe acute respiratory syndrome and other respiratory infections’, The Lancet Infectious Diseases 4, 11, 2004, 684–689, p. 689.
50. Y.S. Wong and G. Chan, The SAF SARS Diaries, Singapore Armed Forces, 2004, pp. 27–28.
51. NIC, SARS: Down But Still a Threat, National Intelligence Council, 2003, p. 19.
52. NIC, SARS: Down But Still a Threat, p. 12
53. WHO, World Health Report 2003: Shaping the Future, World Health Organization, 2003, p. 77.
54. Ho and Su, ‘Preparing to prevent severe acute respiratory syndrome and other respiratory infections’, p. 685.
55. J. deLisle, ‘SARS, greater China, and the pathologies of globalisation and transition’, Orbis 47, 4, 2003, 587–604, p. 598.
56. A. Freedman, ‘SARS and regime legitimacy in China’, Asian Affairs 36, 2, 2005, 169–180, p. 178.
57. J. deLisle, ‘SARS, greater China, and the pathologies of globalisation and transition’, p. 588, n582.
58. M. Caballero-Anthony, ‘SARS in Asia: crisis, vulnerabilities, and regional responses’, Asian Survey 45, 3, 2005, 475–495, pp. 483–484.
59. H.-F. Hung, ‘The politics of SARS: containing the perils of globalization by more globalization’, Asian Perspective 28, 1, 2004, 19–44, p. 41.
60. A.S. Ku and H.-L. Wang, ‘The making and unmaking of civic solidarity: comparing the coping responses in Hong Kong and Taiwan during the SARS crisis’, Asian Perspective 28, 1, 2004, 121–147, p. 136.
61. P. Fidler, SARS and International Law (American Society of International Law Online, April 2003). Online, available at: www.asil.org/insights/insigh101.htm (accessed 10 October 2005).
62. N. Ma, ‘SARS and the limits of the Hong Kong SAR administrative state’, Asian Perspective 28, 1, 2004, 99–120, pp. 109, 113.
63. P.A. Tambyah, ‘Severe acute respiratory syndrome from the trenches, at a Singapore university hospital’, The Lancet Infectious Diseases 4, 11, 2004, 690–696, pp. 690, 692.
64. R. Borsuk and C. Prystay, ‘Be prepared,’ Far Eastern Economic Review, 21 August 2003, 34–35 at p. 35.
65. A.J. Bollet, Plagues and Poxes: the Impact of Human History on Epidemic Disease, New York: Demos, 2004, p. 227.
66. ABC, Vietnam: SARS and a Lesson in Disease Control (ABC News Online, 30 April 2003). Online, available at: www.abc.net.au/ra/asiapac/programs/s843022.htm (accessed 18 October 2005)
67. A.J. McMichael, ‘Human culture, ecological change, and infectious disease: are we experiencing history’s fourth great transition?’, Ecosystem Health 7, 2, 2001, 107–115, pp. 108–109.
68. WHO, Ten Things You Need to Know about Pandemic Influenza (WHO Online, 14 October 2005). Online, available at: www.who.int/csr/disease/influenza/ pandemic10things/en/index.html (accessed 16 October 2005).
69. W. McKibbin and A. Sidorenko, Global Macroeconomic Consequences of Pandemic Influenza, Sydney: Lowy Institute for International Policy, 2006.
70. K. Stöhr and M. Esveld, ‘Will vaccines be available for the next influenza pandemic?’, Science 306, 5705, 2004, 2195–2196, p. 2195.
71. OIE, Update on Avian Influenza in Animals (Type H5) (OIE Online, 4 September 2006). Online, available at: www.oie.int/downld/AVIAN%20INFLUENZA/A_AI–Asia.htm (accessed 19 September 2006).
72. WHO, Confirmed Human Cases of Avian Influenza A (H5N1) (WHO Online, 19 September 2006). Online, available at: www.who.int/csr/disease/avian_influenza/ country/en/ (accessed 23 September 2006).
73. K. Ungchusak, P. Auewarakul, S.F. Dowell, R. Kitphati, W. Auwanit, P. Putha-vathana, M. Uiprasertkul, K. Boonnak, C. Pittayawonganon, N.J. Cox, S.R. Zaki, P. Thawatsupha, M. Chittaganpitch, R. Khontong, J.M. Simmerman and S. Chunsutthiwat, ‘Probable person-to-person transmission of avian influenza A (H5N1)’, New England Journal of Medicine 352, 4, 2005, 333–340.
74. A. Sipress, ‘Bird flu in Indonesian family may raise global alert level’, Washington Post, 25 May 2006, A21.
75. v. Riel, V.J. Munster, E.d. Wit, G.F. Rimmelzwaan, R.A.M. Fouchier, A.D.M.E. Osterhaus and T. Kuiken, ‘H5N1 virus attachment to lower respiratory tract’, Science 312, 2006, 399.
76. D. Lague, ‘Stopping a killer’, Far Eastern Economic Review, 5 February 2004, 12–16, pp. 15–16
77. A. Sipress, ‘Indonesia neglected bird flu until too late, experts say’, Washington Post, 20 October 2005, A01.
78. T. Palmer, Indonesia Admits It Had Bird Flu Warning in November (ABC News Online, 26 January 2004). Online, available at: www.abc.net.au/news/ newsitems/s1031950.htm (accessed 20 June 2004).
79. S.W. Crispin and T. McCawley, ‘Did governments make it worse?’, Far Eastern Economic Review 5 February 2004, 14–15, p. 14.
80. A. Sipress, ‘Strategy on bird flu has human risks, officials say’, Washington Post, 28 January 2004, A15.
81. D. MacKenzie, Bird Flu Outbreak Started a Year Ago (New Scientist Online, 28 January 2004).
82. D. Normile, ‘Vaccinating birds may help to curtail virus’s spread’, Science 306, 5695, 2004, 398–399, p. 399.
83. J. Watts, ‘Vietnam needs cash to stave off future outbreaks of bird flu’, The Lancet 365, 9473, 2005, 1759–1760.
84. M. Cohen and B. McKay, ‘Major flaws in flu detection’, Far Eastern Economic Review, 12 February 2004, 18–20
85. D. Normile, ‘Vietnam battles bird flu. and critics’, Science 309, 5733, 2005, 368–373, p. 372.
86. K. Bradsher and L.K. Altman, ‘Thais infected with bird flu; virus spreads’, New York Times, 24 January 2004, A6.
87. BBC, World Appeal to Contain Bird Flu (BBC News Online, 27 January 2004).
88. H. Chen, G. Deng, Z. Li, G. Tian, Y. Li, P. Jiao, L. Zhang, Z. Liu, R.G. Webster and K. Yu, ‘The evolution of H5N1 influenza viruses in ducks in southern China’, Proceedings of the National Academy of Sciences 101, 28, 2004, 10452–10457.
89. Nakashima, ‘Officials urge farm overhauls to avert bird flu pandemic’, Washington Post, 26 February 2005, A16
90. D. Normile, ‘Ducks may magnify threat of avian flu virus’, Science 306, 5698, 2004, 953.
91. R. Webster and D. Hulse, ‘Controlling avian flu at the source’, Nature 435, 7041, 2005, 415–416, p. 415.
92. D. Butler, ‘“Refusal to share” leaves agency struggling to monitor bird flu’, Nature 435, 7039, 2005, 131.
93. M.H. Cheng, ‘Cash boost for avian influenza exceeds expectations’, The Lancet 367, 9507, 2006, 289.
94. WHO, National Influenza Pandemic Plans (WHO Online). Online, available at: www.who.int/csr/disease/influenza/nationalpandemic/en/index.html (accessed 2 September 2006).
95. A. Abbott, ‘What’s in the medicine cabinet?’, Nature 435, 7041, 2005, 407–409, p. 409.
96. A. Sipress, ‘Countries hit hard by bird flu have little medicine to treat humans’, Washington Post, 6 July 2005, A09.
97. M. Enserink, ‘Oseltamivir becomes plentiful-but still not cheap’, Science 312, 2006, 382–383.
98. J. Kaiser, ‘Facing down pandemic flu, the world’s defenses are weak’, Science 306, 5695, 2004, 394–397, p. 397.
99. S. Brett and A. Zuger, ‘The run on Tamiflu-should physicians prescribe on demand?’, New England Journal of Medicine 353, 25, 2005, 2636–2637.
100. M.D. de Jong, T.T. Thanh, T.H. Khanh, V.M. Hien, G.J.D. Smith, N.V. Chau, V. Cam, P.T. Qui, D.Q. Ha, Y. Guan, J.S.M. Peiris, T.T. Hien, and J. Farrar, ‘Oseltamivir resistance during treatment of influenza A (H5N1) infection’, New England Journal of Medicine 353, 25, 2005, 2667–2672.
101. M. Longini, Jr., A. Nizam, S. Xu, K. Ungchusak, W. Hanshaoworakul, D.A.T. Cummings and M.E. Halloran, ‘Containing pandemic influenza at the source’, Science 309, 5737, 2005, 1083–1087.
102. M.T. Osterholm, ‘A weapon the world needs’, Nature 435, 7041, 2005, 417–418
103. B. Roberts and Y. Lu, ‘Infectious diseases in Asia: implications for global health’, in AIDS in Asia, Y. Lu and M. Essex (eds), New York: Kluwer, 2004, p. 395.
104. B.E. Zimmerman and D.J. Zimmerman, Killer Germs: Microbes and Diseases That Threaten Humanity, New York: Contemporary Books, 2003, p. 146.
105. WHO, WHO Global Influenza Preparedness Plan, Geneva: World Health Organization, 2005, p. 15.
106. D. Cronin, ‘Bird flu scary but not yet imminent’, Canberra Times 22 October 2005, B4.
107. S. Levine, ‘Leaders share flu pandemic concerns’, Washington Post 7 November 2005, B01.
108. S. Tendler, Flu Doctors to be Given Police Guards (The Times Online, 2 November 2005). Online, available at: www.timesonline.co.uk/article/0,25149–|1853843,00.html (accessed 23 December 2005).
109. W. Orent, ‘The fear contagion’, Washington Post 16 October 2005, B01.
110. D. Brown, ‘Military’s role in a flu pandemic’, Washington Post 5 October 2005, A05.
111. N. Ma, ‘SARS and the limits of the Hong Kong SAR administrative state’, Asian Perspective 28, 1, 2004, 99–120, p. 112.
112. H. Cao, T. Nguyen and N. Daniels, ‘HIV/AIDS and public health care in the greater Mekong River region’, in AIDS in Asia, Y. Lu and M. Essex (eds), New York: Kluwer, 2004, pp. 62–63.
113. M.C. Lim-Quizon, ‘HIV/AIDS in the Philippines’, in AIDS in Asia, Y. Lu and M. Essex (eds), New York: Kluwer, 2004, p. 100.
114. H. Nomura and T. Nakayama, ‘The Japanese healthcare system’, British Medical Journal 331, 7518, 2005, 648–649.
115. V. Thamlikitkul, V. Tangcharoensathien and N. Bhamarapravati, ‘Infectious diseases and the development of health systems in Thailand’, in AIDS in Asia, Y. Lu and M. Essex (eds), New York: Kluwer, 2004, pp. 284, 287.
116. T. Kuiken, F.A. Leighton, R.A.M. Fouchier, J.W. LeDuc, J.S.M. Peiris, A. Schudel, K. Stohr and A.D.M.E. Osterhaus, ‘Pathogen surveillance in animals’, Science 309, 5741, 2005, 1680–1681.
117. M. Kim, J. Lee and J.-S. Lee, ‘The history of HIV and other infectious diseases in the Republic of Korea’, in AIDS in Asia, Y. Lu and M. Essex (eds), New York: Kluwer, 2004, p. 310.
118. Ahmad, ‘Dengue death toll rises in Indonesia’, The Lancet 363, 9413, 2004, 956
119. P. Das, ‘Dengue in Indonesia’, The Lancet Infectious Diseases 4, 4, 2004, 195.
120. S. Ku and H.-L. Wang, ‘The making and unmaking of civic solidarity: comparing the coping responses in Hong Kong and Taiwan during the SARS crisis’, Asian Perspective 28, 1, 2004, 121–147, p. 136.
121. K. Bradsher, The Front Lines in the Battle Against Avian Flu are Running Short of Money (New York Times Online, 9 October 2005). Online, available at: www.nytimes.com/2005/10/09/international/asia/09birdflu.html (accessed 9 October 2005).
122. J. Brower and P. Chalk, The Global Threat of New and Reemerging Infectious Diseases: Reconciling US National Security and Public Health Policy, Santa Monica: RAND, 2003, p. 104.
123. D. Thompson, ‘Pre-empting an HIV/AIDS disaster in China’, Seton Hall Journal of Diplomacy and International Relations 4, 2, 2003, 29–44, pp. 30–31.
124. D. Blumenthal and W. Hsiao, ‘Privatization and its discontents – the evolving Chinese health care system’, New England Journal of Medicine 353, 11, 2005, 1165–1170, p. 1166.
125. Y. Huang, Mortal Peril: Public Health in China and its Security Implications, Washington, DC: Chemical and Biological Arms Control Institute, 2003, p. 15.
126. X. Xu, ‘The impact of SARS on China’, Seton Hall Journal of Diplomacy and International Relations 4, 2, 2003, 45–57, p. 52.
127. Wang, L. Kong, F. Wu, Y. Bai and R. Burton, ‘Preventing chronic diseases in China’, The Lancet 366, 9499, 2005, 1821–1824, p. 1822.
128. ABC, Australia Commits $100m to Bird Flu Fight (ABC News Online, 19 November 2005). Online, available at: www.abc.net.au/news/newsitems/200511/ s1510516.htm (accessed 30 December 2005).
129. J.W. Tappero, T. Siraprapasiri, W.C. Levine, S. Thanprasertsuk, S. Dowell, K. Limpakarnjanarat and T.D. Mastro, ‘The Thailand MoPH-US CDC collaboration in Asia’, in AIDS in Asia, Y. Lu and M. Essex (eds), New York: Kluwer, 2004, pp. 551, 553.
130. WHO, International Health Regulations (WHO Online, 2006). Online, available at: www.who.int/csr/ihr/en/ (accessed 24 August 2006).
131. O. Gostin, ‘International infectious disease law: revision of the World Health Organization’s International Health Regulations’, Journal of the American Medical Association 291, 21, 2004, 2623–2627, p. 2625.
132. D.P. Fidler, Germs, Norms and Power: Global Health’s Political Revolution (Law, Social Justice & Global Development Online, 4 June 2004). Online, available at: www2.warwick.ac.uk/fac/soc/law/elj/lgd/2004_1/fidler/ (accessed 19 September 2006).
133. WHO, Public Health Response to Biological and Chemical Weapons: WHO Guidance (WHO Online, 2004). Online, available at: www.who.int/csr/delibepidemics/biochemguide/en/ (accessed 13 February 2005).
134. US Senate Committee on Foreign Relations, ‘The threat of bioterrorism and the spread of infectious diseases’ (hearing transcript), 5 September 2001, p. 78.
135. D. Normile, ‘Who controls the samples?’, Science 309, 5733, 2005, 372–373.
136. T.V. Inglesby, D.A. Henderson, J.G. Bartlett, M.S. Ascher, E. Eitzen, A.M. Friedlander, J. Hauer, J. McDade, M.T. Osterholm, T. O’Toole, G. Parker, T.M. Perl, P.K. Russell and K. Tonat, ‘Anthrax as a biological weapon: medical and public health management’, Journal of the American Medical Association 281, 18, 1999, 1735–1745, p. 1740.
137. M. Dando, ‘Bioterrorism: what is the real threat?’, Department of Peace Studies, University of Bradford, 2005, p. 14.
138. WHO, Health Aspects of Chemical and Biological Weapons, Geneva: World Health Organization, 1970, pp. 98–99.
139. OTA, Proliferation of Weapons of Mass Destruction: Assessing the Risks, Office of Technology Assessment, US Congress, 1993, pp. 53–55.
140. OTA, Technologies Underlying Weapons of Mass Destruction, Office of Technology Assessment, US Congress, 1993, pp. 93–94, 97.
141. W. Hedberg, J.B. Bender and D. Vesley, ‘Protecting food, water, and ambient air’, in Terrorism and Public Health: a Balanced Approach to Strengthening Systems and Protecting People, B.S. Levy and V.W. Sidel (eds), New York: Oxford University Press, 2003, pp. 310–312
142. R.M. Salerno, J. Gaudioso, R.L. Frerichs and D. Estes, ‘A BW risk assessment: historical and technical perspectives’, Nonproliferation Review 11, 3, 2004, 25–55, p. 44.
143. T.J. Torok, R.V. Tauxe, R.P. Wise, J.R. Livengood, R. Sokolow, S. Mauvais, K.A. Birkness, M.R. Skeels, J.M. Horan and L.R. Foster, ‘A large community outbreak of salmonellosis caused by intentional contamination of restaurant salad bars’, Journal of the American Medical Association 278, 5, 1997, 389–395.
144. R.R. Kiziah, ‘Assessment of the emerging biocruise threat’, in The Gathering Biological Warfare Storm, J.A. Davis and B.R. Schneider (eds), Westport: Praeger, 2004, p. 149.
145. J.W. Powell, ‘A hidden chapter in history’, Bulletin of the Atomic Scientists 37, 8, 1981, 44–52, p. 51.
146. S.B. Martin, ‘The role of biological weapons in international politics: the real military revolution’, Journal of Strategic Studies 25, 1, 2002, 63–98, pp. 65–66.
147. T. Mangold and J. Goldberg, Plague Wars: a True Story of Biological Warfare, London: Macmillan, 1999, pp.17–18.
148. K. Alibek, Biohazard, London: Arrow, 1999, p. 166.
149. P. Williams and D. Wallace, Unit 731: the Japanese Army’s Secret of Secrets, London: Hodder and Stoughton, 1989, pp. 26–27.
150. J. Ban, Health, Security, and US Global Leadership, Chemical and Biological Arms Control Institute, 2001, p. 18
151. D. Barenblatt, A Plague Upon Humanity: the Hidden History of Japan’s Biological Warfare Program, New York: HarperCollins, 2004, p. xii
152. Z. Yunhua, ‘China: balancing disarmament and development’, in Biological Warfare and Disarmament: New Problems/New Perspectives, S. Wright (ed.), Lanham: Rowman and Littlefield, 2002, p. 214.
153. S. Endicott and E. Hagerman, The United States and Biological Warfare: Secrets From the Early Cold War and Korea, Bloomington, IN: Indiana University Press, 1998, pp. 37–38, 41.
154. J.W. Powell, ‘A hidden chapter in history’, Bulletin of the Atomic Scientists 37, 8, 1981, 44–52.
155. M. Leitenberg, ‘Resolution of the Korean War biological warfare allegations’, Critical Reviews in Microbiology 24, 3, 1998, 169–194, pp. 170, 172.
156. Wilde and R.N. Johnson, ‘Book review: The United States and Biological Warfare: Secrets From the Early Cold War and Korea’, Journal of the American Medical Association 282, 19, 1999, 1877–1878.
157. H. Wilde, ‘Biological warfare in the 1940s and 1950s’, Journal of the American Medical Association 284, 5, 2000, 562.
158. M. Leitenberg, ‘New Russian evidence on the Korean War biological warfare allegations: background and analysis’, Cold War International History Project Bulletin 11, 1998, 185–199, p. 187.
159. K. Weathersby, ‘Deceiving the deceivers: Moscow, Beijing, Pyongyang, and the allegations of bacteriological weapons use in Korea’, Cold War International History Project Bulletin, 11, 1998, 176–185, pp. 176–177.
160. A. Selth, Burma and Weapons of Mass Destruction, Working Paper 334, Canberra: Strategic and Defence Studies Centre, Australian National University, 1999.
161. E.D. Harris, ‘Threat reduction and North Korea’s CBW programs’, Nonproliferation Review 11, 3, 2004, 86–109, p. 189.
162. CIA, Unclassified Report to Congress on the Acquisition of Technology Relating to Weapons of Mass Destruction and Advanced Conventional Munitions, 1 July Through 31 December 2003 (CIA Online, November 2004). Online, available at: www.cia.gov/cia/ reports/721_reports/july_dec2003.htm (accessed 30 December 2005).
163. K.-S. Kim, ‘North Korea’s CB weapons: threat and capability’, Korean Journal of Defense Analysis 14, 1, 2002, 69–95, p. 84.
164. J.S. Bermudez, Shield of the Great Leader: the Armed Forces of North Korea, Sydney: Allen and Unwin, 2001, p. 150.
165. WHO, Country Health Profile – DPR Korea (WHO Southeast Asia Regional Office Online, 29 October 2003). Online, available at: w3.whosea.org/cntry– health/dprkorea/index.htm (accessed 22 July 2005).
166. J. Miller, S. Engelberg and W. Broad, ‘US germ warfare research pushes treaty limits’, New York Times, 4 September 2001, A1.
167. CIA, Unclassified Report to Congress on the Acquisition of Technology Relating to Weapons of Mass Destruction and Advanced Conventional Munitions (URL cited). Proliferation: Threat and Response, p. 17
168. A. Mauroni, Chemical and Biological Warfare: a Reference Handbook, Santa Barbara: ABC-CLIO, 2003, p. 64
169. CBS, Secret Weapon vs. Taiwan’s SARS (CBS News Online, 20 May 2003). Online, available at: www.cbsnews.com/stories/2003/05/20/health/main 554764.shtml (accessed 13 May 2005)
170. W. Minnick, ‘Taiwan’s secret research unveiled’, Jane’s Defence Weekly, 4 June 2003, 13.
171. J. Stern, ‘Dreaded risks and the control of biological weapons’, International Security 27, 3, 2002, 89–123, pp. 104, 121.
172. M.B.A. Oldstone, Viruses, Plagues, and History, New York: Oxford University Press, 1998, pp. 29–30.
173. A.J. Bollet, Plagues and Poxes: the Impact of Human History on Epidemic Disease, New York: Demos, 2004, p. 206
174. J. Stern, ‘The prospect of domestic bioterrorism’, Emerging Infectious Diseases 5, 4, 1999, 517–522, pp. 518–519.
175. A. Dolnik and J. Pate, ‘Mass casualty terrorism: understanding the bioterrorist threat’, in The Changing Face of Terrorism, R. Gunaratna (ed.), Singapore: Eastern Universities Press, 2004, p. 109
176. G. Koblentz, ‘Pathogens as weapons: the international security implications of biological warfare’, International Security 28, 3, 2004, 84–122, p. 103
177. A.M. Muir, ‘Terrorism and weapons of mass destruction: the case of Aum Shinrikyo’, Studies in Conflict and Terrorism 22, 1, 1999, 79–97, p. 81
178. J.B. Tucker, ‘Historical trends related to bioterrorism: an empirical analysis’, Emerging Infectious Diseases 5, 4, 1999, 498–504, p. 503.
179. T.J. Torok, R.V. Tauxe, R.P. Wise, J.R. Livengood, R. Sokolow, S. Mauvais, K.A. Birkness, M.R. Skeels, J.M. Horan and L.R. Foster, ‘A large community outbreak of salmonellosis caused by intentional contamination of restaurant salad bars’, Journal of the American Medical Association 278, 5, 1997, 389–395, p. 390.
180. S. Gressang, ‘Audience and message: assessing terrorist WMD potential’, Terrorism and Political Violence 13, 3, 2001, 83–106, pp. 185, 190.
181. J. Parachini, ‘Putting WMD terrorism into perspective’, Washington Quarterly 26, 4, 2003, 37–50, p. 45.
182. M.T. Osterholm and J. Schwarz, Living Terrors: What America Needs to Know to Survive the Coming Bioterrorist Catastrophe, New York: Delacourt Press, 2000, pp.24, 78, 91.
183. ABC, Biowar (ABC Online, 4 September 2005). Online, available at: www.abc.net.au/rn/talks/bbing/stories/s1450124.htm (accessed 8 September 2005).
184. W. Laqueur, The New Terrorism: Fanaticism and the Arms of Mass Destruction, New York: Oxford University Press, 1999, p. 65.
185. M. Dando, Bioterrorism: What is the Real Threat?, Department of Peace Studies, University of Bradford, 2005, p. 27.
186. R. Danzig, Catastrophic Bioterrorism – What is to be Done? Washington, DC: National Defense University, 2003, p. 2.
187. A. Haselkorn, ‘Iraq’s biowarfare option: last resort, pre-emption, or a blackmail weapon?’, Biosecurity and Bioterrorism 1, 1, 2003, 19–26, p. 24.
188. J. Gearson, ‘The nature of modern terrorism’, in Superterrorism: Policy Responses, L. Freedman (ed.), Oxford: Blackwell, 2002, p. 21
189. J.B. Tucker, ‘Biological threat assessment: is the cure worse than the disease?’, Arms Control Today 34, 2004, 13–19, pp. 13–14.
190. G. Matsumoto, ‘Anthrax powder: state of the art?’, Science 302, 5650, 2003, 1492–1497, p. 1493.
191. M. Leitenberg, ‘Biological weapons and bioterrorism in the first years of the twenty-first century’, Politics and the Life Sciences 21, 2, 2002, 3–27, p. 19.
192. J. Miller, S. Engelberg and W. Broad, Germs: the Ultimate Weapon, Sydney: Simon & Schuster, 2001, pp. 297–298.
193. CIA, Terrorist CBRN: Material and Effects, Central Intelligence Agency, 2003, p.2.
194. G. Alcorn, Crop Spraying: Techniques and Equipment, Sydney: Inkata Press, 1993, pp. 85–87
195. E. Croddy, Chemical and Biological Warfare: a Comprehensive Survey for the Concerned Citizen, New York: Copernicus, 2002, p. 82.
196. D.B. Levin and G.V.d. Amorim, ‘Potential for aerosol dissemination of biological weapons: lessons from biological control of insects’, Biosecurity and Bioterrorism 1, 1, 2003, 37–42, p. 41.
197. T.V. Inglesby, D.A. Henderson, J.G. Bartlett, M.S. Ascher, E. Eitzen, A.M. Friedlander, J. Hauer, J. McDade, M.T. Osterholm, T. O’Toole, G. Parker, T.M. Perl, P.K. Russell and K. Tonat, ‘Anthrax as a biological weapon: medical and public health management’, Journal of the American Medical Association 281, 18, 1999, 1735–1745, p. 1737.
198. M. Enserink, ‘How devastating would a smallpox attack really be?’, Science 296, 5573, 2002, 1592–1595, p. 1592.
199. M.L. Wheelis, ‘Investigations of suspicious outbreaks of disease’, in Biological Warfare: Modern Offense and Defense, R.A. Zilinskas (ed.), Boulder, CO: Lynne Rienner, 2000, p. 109.
200. Abdel-Aziz, The Mujahideen Poisons Handbook (The Disease.Net Online, 1996). Online, available at: www.thedisease.net/arcana/nbc/chemical/Mujahideen_ Poisons.pdf (accessed 21 August 2005).
201. CIA, Unclassified Report to Congress on the Acquisition of Technology Relating to Weapons of Mass Destruction and Advanced Conventional Munitions, 1 July Through 31 December 2003 (CIA Online, November 2004).
202. CBS, Is Al Qaeda Making Anthrax? (CBS News Online, 9 October 2003). Online, available at: www.cbsnews.com/stories/2003/10/09/eveningnews/ main577395.shtml (accessed 27 June 2004).
203. A. Thayer, ‘Political terrorism in Southeast Asia’, Pointer 29, 4, 2003, 53–62, pp. 56–60.
204. W. Rosenau, ‘Aum Shinrikyo’s biological weapons program: why did it fail?’, Studies in Conflict and Terrorism 24, 4, 2001, 289–301, p. 291.
205. K.B. Olson, ‘Aum Shinrikyo: once and future threat?’, Emerging Infectious Diseases 5, 4, 1999, 513–516, p. 515.
206. A.P. Schmid, ‘Terrorism and the use of weapons of mass destruction: from where the risk?’, in The Future of Terrorism, M. Taylor and J. Horgan (eds), London: Frank Cass, 2000, pp. 124–125.
207. K. Alibek, Biohazard, London: Arrow, 1999, p. 278.
208. H. Takahashi, P. Keim, A.F. Kaufmann, C. Keys, K.L. Smith, K. Taniguchi, S. Inouye and T. Kurata, ‘Bacillus anthracis incident, Kameido, Tokyo, 1993’, Emerging Infectious Diseases 10, 1, 2004, 117–120.
209. T. Ballard, J. Pate, G. Ackerman, D. McCauley and S. Lawson, Chronology of Aum Shinrikyo’s CBW Activities (Monterey Institute of International Studies Online, 15 March 2001). Online, available at: cns.miis.edu/pubs/reports/ aum_chrn.htm (accessed 16 August 2005).
210. P. Kallender, ‘Rising to meet terror threat’, Defense News 5 May 2003, 18.
211. NAS, Chemical and Biological Terrorism: Research and Development to Improve Civilian Medical Response, Washington, DC: National Academy of Sciences, 1999, p. 13.
212. T.J. Torok, R.V. Tauxe, R.P. Wise, J.R. Livengood, R. Sokolow, S. Mauvais, K.A. Birkness, M.R. Skeels, J.M. Horan and L.R. Foster, ‘A large community outbreak of salmonellosis caused by intentional contamination of restaurant salad bars’, Journal of the American Medical Association 278, 5, 1997, 389–395, p. 393.
213. G. Gompert, ‘Sharpen the fear’, Bulletin of the Atomic Scientists 56, 1, 2000, 22–23, pp. 22–23.
214. R.R. Kiziah, ‘Assessment of the emerging biocruise threat’, in The Gathering Biological Warfare Storm, J.A. Davis and B.R. Schneider (ed.), Westport, CT: Praeger, 2004, p. 130.
215. S. Haeri, WMD Transport Targeted on High Seas (Asia Times Online, 12 September 2003). Online, available at: www.atimes.com/atimes/Korea/EI12Dg01.html (accessed 24 November 2003).
216. S. Sakamaki and D. Struck, ‘Japan cracks down on firms tied to N. Korea’, Washington Post 22 May 2003, A23.
217. CIA, Unclassified Report to Congress on the Acquisition of Technology Relating to Weapons of Mass Destruction and Advanced Conventional Munitions, 1 July Through 31 December 2003 (CIA Online, November 2004). Online, available at: www.cia.gov/cia/reports/721_reports/july_dec2003.htm (accessed 30 December 2005).
218. CIA and DIA, Iraqi Mobile Biological Warfare Agent Production Plants, Central Intelligence Agency and Defense Intelligence Agency, 2003, pp. 1–4.
219. J. Miller and W.J. Broad, ‘Some analysts of Iraq trailers reject germ use’, New York Times 7 June 2003, A1.
220. CIA and DIA, Iraqi Mobile Biological Warfare Agent Production Plants, p. 5.
221. D. Jehl, ‘Iraqi trailers said to make hydrogen, not biological arms’, New York Times 9 August 2003, A1.
222. CIA and DIA, Iraqi Mobile Biological Warfare Agent Production Plants, p. 1.
223. M. Dando, ‘Genomics, bioregulators, cell receptors and potential biological weapons’, Defense Analysis 17, 3, 2001, 239–258, p. 242
224. J.-W. Guo and X.-S. Yang, ‘Ultramicro, nonlethal, and reversible: looking ahead to military biotechnology’, Military Review July-August 2005, 75–78.
225. P. Moore, Killer Germs: Rogue Diseases of the Twenty-First Century, London: Carlton, 2001, p. 1.
226. VERTIC, Time to Lay Down the Law: the Status of National Laws to Enforce the BWC, Verification Research, Training and Information Centre, 2003, p. 11.
227. R.O. Korea, Note Verbale Dated 27 October 2004 from the Permanent Mission of the Republic of Korea to the United Nations Addressed to the Chairman of the Committee (1540 Committee, UN Online, 27 October 2004). Online, available at: www.un.org/Docs/journal/asp/ws.asp?m=S/AC.44/2004/(02)/24 (accessed 31 December 2005).
228. VERTIC, Biological Weapons Convention: Collection of National Implementation Legislation (VERTIC Online, 2003). Online, available at: www.vertic.org/datasets/bwlegislation.html (accessed 3 September 2005).
229. P.R. Chari and G. Deshingkar, ‘Putting teeth in the BWC: an Indian view’, Politics and the Life Sciences 18, 1, 1999, 86–91, p. 88.
230. Z. Yunhua, ‘China: balancing disarmament and development’, in Biological Warfare and Disarmament: New Problems/New Perspectives, S. Wright (ed.), Lanham: Rowman and Littlefield, 2002, pp. 224, 231.
231. N. Wisnumurti, Statement by Head of Delegation of the Republic of Indonesia, Fifth Review Conference of the States Parties to the Convention on the Prohibition of the Development, Production and Stockpiling of Bacteriological (Biological) and Toxin Weapons and on Their Destruction, 2001.
232. Y. Huang, Mortal Peril: Public Health in China and its Security Implications, Washington, DC: Chemical and Biological Arms Control Institute, 2003, p. 2.
233. J. Lord, ‘Exercises involving an act of biological or chemical terrorism: what are the psychological consequences?’, Military Medicine 166, Supplement 2, 2001, 34–35.
234. E. Norwood, ‘Psychological effects of biological warfare’, Military Medicine 166, Supplement 2, 2001, 27–28
235. V. Ramalingaswarmi, ‘Psychosocial effects of the 1994 plague outbreak in Surat, India’, Military Medicine 166, Supplement 2, 2001, 29–30.
236. WHO, Preparedness for the Deliberate Use of Biological Agents: a Rational Approach to the Unthinkable, Geneva: World Health Organization, 2002, pp. 2–4.
237. UN, A More Secure World: Our Shared Responsibility. Report of the High-Level Panel on Threats, Challenges and Change, United Nations, 2004, p. 47.
238. R. Brookmeyer, E. Johnson and R. Bollinger, ‘Public health vaccination policies for containing an anthrax outbreak’, Nature 432, 7019, 2004, 901–904.
239. L.T. Hickok and R.M. Salerno, Time to Wake up to Bioterror Threat (Straits Times Online, 26 January 2004). Online, available at: straitstimes.asia1.com.sg/storyprintfriendly/0,1887,231848,00.html (accessed 29 January 2004).
240. G.W. Christopher, T.J. Cieslak, J.A. Pavin and E.M. Eitzen, ‘Biological warfare: a historical perspective’, Journal of the American Medical Association 278, 5, 1997, 412–417, p. 416.
241. J. Miller, ‘Russian scientist dies in Ebola accident at former weapons lab’, New York Times 25 May 2004, A9.
242. F. James, ‘Anti-bioterror labs raise risk to US, critics say’, Chicago Tribune 5 December 2004, 9
243. J. Kaiser, ‘Citizens sue to block Montana biodefense lab’, Science 305, 5687, 2004, 1088.
244. D. Normile and G. Vogel, ‘Early indications point to lab infection in new SARS case’, Science 301, 5640, 2003, 1642–1643.
245. WHO, Biosafety and SARS incident in Singapore, September 2003, WHO Western Pacific Regional Office, 2003, pp. 12–14.
246. D. Normile, ‘Second lab accident fuels fears about SARS’, Science 303, 2004, 26
247. BBC, China Finds Suspected SARS Case (BBC News Online, 22 April 2004). Online, available at: news.bbc.co.uk/2/hi/asia-pacific/3649897.stm (accessed 31 December 2005)
248. D. Murphy, ‘Lab bungle’, Far Eastern Economic Review 6 May 2004, 18
249. J. Yardley and L.K. Altman, ‘China is scrambling to curb SARS cases after a death’, New York Times 24 April 2004, 4.
250. J. Yardley, ‘China expands quarantine in aggressive effort to contain SARS’, New York Times 27 April 2004, 5.
251. W. Chung-ming, Taiwan Government Mobilizes against Contagious Disease (Taiwan News Online, 24 April 2004). Online, available at: www.etaiwannews.com/Taiwan/2004/04/24/1082776673.htm (accessed 25 April 2004).
252. M. Enserink and L. Du, ‘SARS: China dumps CDC head, probes lab’, Science 305, 5681, 2004, 163
253. WHO, Chinese Ministry of Health Summary of China’s Investigation into the April Outbreak (WHO Western Pacific Regional Office Online, 2 July 2004). Online, available at: www.wpro.who.int/sars/docs/update/update_07022004_revisedfinal.asp (accessed 1 May 2005).
254. M. Guihua, ‘China revises law on infectious diseases’, The Lancet Infectious Diseases 4, 11, 2004, 652.
255. Cao, ‘SARS: “Waterloo” of Chinese science’, China: an International Journal 2, 2, 2004, 262–286, p. 283.
256. T.D. Read, S.L. Salzberg, M. Pop, M. Shumway, L. Umayam, L. Jiang, E. Holtzapple, J.D. Busch, K.L. Smith, J.M. Schupp, D. Solomon, P. Keim and C.M. Fraser, ‘Comparative genome sequencing for discovery of novel polymorphisms in Bacillus anthracis’, Science 296, 5575, 2002, 2028–2033.
257. G. Gugliotta, ‘Still no arrests in anthrax probe, but “progress” is noted’, Washington Post 4 August 2002, A08.
258. E. Choffnes, ‘Bioweapons: new labs, more terror?’, Bulletin of the Atomic Scientists 58, 5, 2002, 29–32, p. 29
259. J. Guillemin, Biological Weapons: From the Invention of State-Sponsored Programs to Contemporary Bioterrorism, New York: Columbia University Press, 2005, p. 175
260. G. Matsumoto, ‘Anthrax powder: state of the art?’, Science 302, 5650, 2003, 1492–1497
261. J.B. Tucker, ‘Biological threat assessment: is the cure worse than the disease?’, Arms Control Today 34, 2004, 13–19, p.15.
262. G. Gugliotta, ‘Still no arrests in anthrax probe, but “progress” is noted’, A08.
263. J. Miller, ‘Scientist files suit over anthrax inquiry’, New York Times 27 August 2003, A13.
264. J. Gaudioso and R.M. Salerno, ‘Biosecurity and research: minimizing adverse impacts’, Science 304, 5671, 2004, 687.
265. K. Chang, ‘30 plague vials put career on the line’, New York Times 19 October 2003, p. 32
266. K. Hoyt and S.G. Brooks, ‘A double-edged sword: globalization and biosecurity’, International Security 28, 3, 2004, 123–148, p. 141.
267. E. Murray, K.E. Anderson, K. Arnold, J.G. Bartlett, C.C. Carpenter, S. Falkow, J.T. Hartman, T. Lehman, T.W. Reid, F.M. Ryburn, Jr., R.B. Sack, M.J. Struelens, L.S. Young and W.B. Greenough III, ‘Destroying the life and career of a valued physician-scientist who tried to protect us from plague: was it really necessary?’, Clinical Infectious Diseases 40, 11, 2005, 1644–1648.
268. M. Enserink and D. Malakoff, ‘The trials of Thomas Butler’, Science 302, 5653, 2003, 2054–2063, p. 2057.
269. K. Chang, ‘Scientist in plague case is sentenced to two years’, New York Times 11 March 2004, 18
270. R.M. Atlas and J. Reppy, ‘Globalizing biosecurity’, Biosecurity and Bioterrorism 3, 1, 2005, 51–60
271. M. Barletta, A. Sands and J.B. Tucker, ‘Keeping track of anthrax: the case for a Biosecurity Convention’, Bulletin of the Atomic Scientists 58, 3, 2002, 57–62
272. J.D. Steinbruner and E.D. Harris, ‘Controlling dangerous pathogens’, Issues in Science and Technology 19, 3, 2003, 47–54, p. 53.
273. J.B. Tucker, Biosecurity: Limiting Terrorist Access to Deadly Pathogens, Washington, DC: United States Institute of Peace, 2003, p. 37.
274. S. Wright and S. Ketcham, ‘The problem of interpreting the US biological defense research program’, in Preventing a Biological Arms Race, S. Wright (ed.), Cambridge, MA: MIT Press, 1990, pp. 171–172.
275. H.C. Kelly, ‘Terrorism and the biology lab’, New York Times 2 July 2003, A25
276. M. Moodie, Reducing the Biological Threat: New Thinking, New Approaches, Washington, DC: Chemical and Biological Arms Control Institute, 2003, p. 41.
277. N. Munro, Scientific Community Struggles to Balance Openness, Security (Global Security Newswire Online, 5 September 2003). Online, available at: www.nti.org/d_newswire/issues/newswires/2003_9_5.html#10 (accessed 9 September 2003).
278. NAS, Biotechnology Research in an Age of Terrorism, National Academy of Sciences, 2004, p. 5.
279. R.J. Jackson, A.J. Ramsay, C.D. Christensen, S. Beaton, D.F. Hall and I.A. Ramshaw, ‘Expression of mouse Interleukin-4 by a recombinant ectromelia virus suppresses cytolytic lymphocyte responses and overcomes genetic resistance to mousepox’, Journal of Virology 75, 3, 2001, 1205–1210.
280. J. Cello, A.V. Paul and E. Wimmer, ‘Chemical synthesis of poliovirus cDNA: generation of infectious virus in the absence of natural template’, Science 297, 5583, 2002, 1016–1018.
281. G.L. Epstein, ‘Controlling biological warfare threats: resolving potential tensions among the research community, industry, and the national security community’, Critical Reviews in Microbiology 27, 4, 2001, 321–354, p. 343.
282. J. Couzin, ‘US agencies unveil plan for biosecurity peer review’, Science 303, 5664, 2004, 1595
283. R. Casagrande, ‘Biological warfare targeted at livestock’, BioScience 52, 7, 2002, 577–581.
284. T.M. Tumpey, C.F. Basler, P.V. Aguilar, H. Zeng, A. Solorzano, D.E. Swayne, N.J. Cox, J.M. Katz, J.K. Taubenberger, P. Palese and A. Garcia-Sastre, ‘Characterization of the reconstructed 1918 Spanish influenza pandemic virus’, Science 310, 5745, 2005, 77–80.
285. J. Kaiser, ‘Resurrected influenza virus yields secrets of deadly 1918 pandemic’, Science 310, 5745, 2005, 28–29.
286. P.A. Sharp, ‘1918 flu and responsible science’, Science 310, 5745, 2005, 17.
287. J. Cohen, ‘HHS asks PNAS to pull bioterrorism paper’, Science 308, 5727, 2005, 1395.
288. M. Wein, ‘Got toxic milk?’, New York Times 30 May 2005, A15.
289. M. Wein and Y. Liu, ‘Analyzing a bioterror attack on the food supply: the case of botulinum toxin in milk’, Proceedings of the National Academy of Sciences 102, 28, 2005, 9984–9989.
290. A. McCook, PNAS Publishes Bioterror Paper, After All (The Scientist Online, 29 June 2005). Online, available at: www.the-scientist.com/news/20050629/01 (accessed 1 July 2005).
291. S. Shane, ‘Paper describes potential poisoning of milk’, New York Times 29 June 2005, A20.
292. W. Broad, D. Johnston and J. Miller, ‘Subject of anthrax inquiry tied to antigerm training’, New York Times 2 July 2003, A1
293. M.W. Thompson, ‘Hatfill trained US team on bioweapons’, Washington Post 3 July 2003, A03.
294. Christian Enemark, ‘United States biodefense, international law, and the problem of intent’, Politics and the Life Sciences 24, 1–2, 2005, 32–42.
295. Lam, C. Franco and A. Schuler, ‘Billions for biodefense: federal agency biodefense funding, FY2006-FY2007’, Biosecurity and Bioterrorism 4, 2, 2006, 113–127, p. 114.
296. J. Guillemin, Biological Weapons: From the Invention of State-Sponsored Programs to Contemporary Bioterrorism, New York: Columbia University Press, 2005, p. 199.
297. J. Fiorill, US Plans to Defend Against Engineered Bioattack (Global Security Newswire Online, 15 June 2005). Online, available at: www.nti.org/d_newswire/issues/2005/6/15/F1EB5240–6C65–41F5-A24E-DFD8EFF6C642.html (accessed 1 July 2005).
298. T. Clarke and J. Knight, ‘Fast vaccine offers hope in battle with Ebola’, Nature 424, 6949, 2003, 602
299. N.J. Sullivan, T.W. Geisbert, J.B. Geisbert, L. Xu, Z.-y. Yang, M. Roederer, R.A. Koup, P.B. Jahrling and G.J. Nabel, ‘Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates’, Nature 424, 6949, 2003, 681–684.
300. T.W. Geisbert, L.E. Hensley, P.B. Jahrling, T. Larsen, J.B. Geisbert, J. Paragas, H.A. Young, T.M. Fredeking, W.E. Rote and G.P. Vlasuk, ‘Treatment of Ebola virus infection with a recombinant inhibitor of factor VIIA/tissue factor: a study in rhesus monkeys’, The Lancet 362, 9400, 2003, 1953–1958.
301. M. Enserink and J. Kaiser, ‘Has biodefense gone overboard?’, Science 307, 5714, 2005, 1396–1398, p. 1396.
302. R. Loeppky, ‘“Biomania” and US foreign policy’, Millennium 34, 1, 2005, 85–113.
303. S. Wright and S. Ketcham, ‘The problem of interpreting the US biological defense research program’, in Preventing a Biological Arms Race, S. Wright (ed.), Cambridge, MA: MIT Press, 1990, pp. 176–177.
304. M. Leitenberg, ‘Distinguishing offensive from defensive biological weapons research’, Critical Reviews in Microbiology 29, 3, 2003, 223–257, p. 248.
305. S. Shane, Bioterror Fight May Spawn New Risks (Baltimore Sun Online, 27 June 2004) . Online, available at: www.baltimoresun.com/news/nationworld/bal-te. biodefense27jun27,0,6098679.story (accessed 29 June 2004).
306. R. Nelson, ‘Biosafety laboratories proliferate across the USA’, The Lancet Infectious Diseases 4, 10, 2004, 596.
307. NAS, Biotechnology Research in an Age of Terrorism, National Academy of Sciences, 2004, p. 3.
308. B. Knickerbocker, Concern over Spread of Biodefense Labs (Christian Science Monitor Online, 25 September 2003). Online, available at: www.csmonitor.com/2003/0925/p02s01-uspo.html (accessed 14 July 2004).
309. J.B. Tucker, Scourge: the Once and Future Threat of Smallpox, New York: Atlantic Monthly Press, 2001, p. 145.
310. A.E. Cha, ‘Computers simulate terrorism’s extremes’, Washington Post 4 July A01.
311. H.A. Kissinger, National Security Decision Memorandum (NSDM) 35, United States Policy on Chemical Warfare Program and Bacteriological/Biological Research Program, from National Security Advisory Henry A. Kissinger to the Vice President, the Secretary of State, the Secretary of Defense, etc., November 25, 1969 (George Washington University National Security Archive Online, 7 December 2001). Online, available at: www.gwu.edu/~nsarchiv/NSAEBB/NSAEBB58/RNCBW8.pdf (accessed 27 May 2005).
312. J. Warrick, ‘The secretive fight against bioterror’, Washington Post 30 July 2006, A01.
313. G. Korch, Leading Edge of Biodefense: the National Biodefense Analysis and Countermeasures Center, Lecture to the Department of Defense Pest Management Workshop, Jacksonville Naval Air Station, 9 February 2004 (Bioweapons and Biodefense Freedom of Information Fund Online, 2004). Online, available at: www.cbw-transparency.org/archive/nbacc.pdf (accessed 26 May 2005).
314. CBDP, Chemical and Biological Defense Program Annual Report to Congress, US Department of Defense, 2006, p. 69.
315. J. Miller, S. Engelberg and W. Broad, ‘US germ warfare research pushes treaty limits’, New York Times 4 September 2001, A1.
316. J. Miller, S. Engelberg and W. Broad, Germs: the Ultimate Weapon, Sydney: Simon & Schuster, 2001.
317. A.P. Pomerantsev, N.A. Staritsin, Y.V. Mockov and L.I. Marinin, ‘Expression of cereolysine AB genes in Bacillus anthracis vaccine strain ensures protection against experimental hemolytic anthrax infection’, Vaccine 15, 17/18, 1997, 1846–1850.
318. CBDP, Chemical and Biological Defense Program Annual Report to Congress, US Department of Defense, 2005, pp. 49–50.
319. R.J. Jackson, A.J. Ramsay, C.D. Christensen, S. Beaton, D.F. Hall and I.A. Ramshaw, ‘Expression of mouse Interleukin-4 by a recombinant ectromelia virus suppresses cytolytic lymphocyte responses and overcomes genetic resistance to mousepox’, Journal of Virology 75, 3, 2001, 1205–1210.
320. R. Roos, Scientists Research Antidotes to Super Mousepox Virus (University of Minnesota Online, 6 November 2003). Online, available at: www.cidrap.umn.edu/cidrap/content/bt/smallpox/news/nov0603mousepox.html (accessed 8 November 2003).
321. S. Wright, Taking Biodefense Too Far (Bulletin of the Atomic Scientists Online, November/December 2004). Online, available at: www.thebulletin.org/issues/ 2004/nd04/nd04wright.html (accessed 1 November 2004).
322. J.B. Tucker, ‘Biological threat assessment: is the cure worse than the disease?’, Arms Control Today 34, 2004, 13–19, p. 18.
323. K. Alibek, Biohazard, London: Arrow, 1999, p. 234.
324. W. Broad, ‘Book says pre–Gulf War discovery raised germ warfare fears’, New York Times 7 June 1998, A6.
325. M. Kelley and J. Coghlan, ‘Mixing bugs and bombs’, Bulletin of the Atomic Scientists 59, 5, 2003, 24–31.
326. V. Futrakul, Statement of the Permanent Representative of Thailand, Fifth Review Conference of the States Parties to the Convention on the Prohibition of the Development, Production and Stockpiling of Bacteriological (Biological) and Toxin Weapons and on Their Destruction, 2001.